Literature DB >> 11502544

Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients.

H Servais1, P M Tulkens.   

Abstract

The stability and compatibility of ceftazidime have been examined in the context of its potential use in concentrated solutions for continuous infusion in patients suffering from severe nosocomial pneumonia and receiving other intravenous medications by the same route. Ceftazidime stability in 4 to 12% solutions was found satisfactory (<10% degradation) for 24 h if kept at a temperature of 25 degrees C (77 degrees F) maximum. Studies mimicking the simultaneous administration of ceftazidime and other drugs as done in clinics showed physical incompatibilities with vancomycin, nicardipine, midazolam, and propofol and a chemical incompatibility with N-acetylcystein. Concentrated solutions (50 mg/ml) of erythromycin or clarithromycin caused the appearance of a precipitate, whereas gentamicin, tobramycin, amikacin, isepamicin, fluconazole, ketamine, sufentanil, valproic acid, furosemide, uradipil, and a standard amino acid solution were physically and chemically compatible.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11502544      PMCID: PMC90707          DOI: 10.1128/AAC.45.9.2643-2647.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  30 in total

1.  Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration.

Authors:  E Lor; T Sheybani; J Takagi
Journal:  Am J Hosp Pharm       Date:  1991-04

2.  Intramolecular nucleophilic attack of an ureido group on the beta-lactam carbonyl moiety of penicillins.

Authors:  H Bundgaard
Journal:  Acta Pharm Suec       Date:  1973-09

Review 3.  Penicillins and cephalosporins. Physicochemical properties and analysis in pharmaceutical and biological matrices.

Authors:  P C Van Krimpen; W P Van Bennekom; A Bult
Journal:  Pharm Weekbl Sci       Date:  1987-02-20

4.  Effect of storage of penicillin-G solutions on sensitisation to penicillin-G after intravenous administration.

Authors:  K A Neftel; M Wälti; H Spengler; A L de Weck
Journal:  Lancet       Date:  1982-05-01       Impact factor: 79.321

5.  Chemical stabilities of cefoperazone sodium and ceftazidime in 5% dextrose and 0.9% sodium chloride injections.

Authors:  V Das Gupta; C Bethea; M dela Torre
Journal:  J Clin Pharm Ther       Date:  1988-06       Impact factor: 2.512

6.  Adverse reactions following intravenous penicillin-G relate to degradation of the drug in vitro.

Authors:  K A Neftel; M Wälti; H K Schulthess; J Gubler
Journal:  Klin Wochenschr       Date:  1984-01-02

7.  Comparative stability of cephalosporins in aqueous solution: kinetics and mechanisms of degradation.

Authors:  T Yamana; A Tsuji
Journal:  J Pharm Sci       Date:  1976-11       Impact factor: 3.534

8.  Stability of cefazolin sodium, cefoxitin sodium, ceftazidime, and penicillin G sodium in portable pump reservoirs.

Authors:  M L Stiles; Y H Tu; L V Allen
Journal:  Am J Hosp Pharm       Date:  1989-07

9.  Stability of ceftazidime and amino acids in parenteral nutrient solutions.

Authors:  C S Wade; V Lampasona; R E Mullins; R B Parks
Journal:  Am J Hosp Pharm       Date:  1991-07

10.  Tobramycin inactivation by carbenicillin, ticarcillin, and piperacillin.

Authors:  H Konishi; M Goto; Y Nakamoto; I Yamamoto; H Yamashina
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

View more
  8 in total

Review 1.  Systematic review of stability data pertaining to selected antibiotics used for extended infusions in outpatient parenteral antimicrobial therapy (OPAT) at standard room temperature and in warmer climates.

Authors:  Stephen John Perks; Cassie Lanskey; Niechole Robinson; Tilley Pain; Richard Franklin
Journal:  Eur J Hosp Pharm       Date:  2019-06-20

2.  Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure.

Authors:  Federico Pea; Pierluigi Viale; Daniela Damiani; Federica Pavan; Francesco Cristini; Renato Fanin; Mario Furlanut
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

Review 3.  Is antibiotic resistance a problem? A practical guide for hospital clinicians.

Authors:  G Barlow; D Nathwani
Journal:  Postgrad Med J       Date:  2005-11       Impact factor: 2.401

4.  Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units).

Authors:  Eric Viaene; Hugues Chanteux; Hélène Servais; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 5.  Selecting antibacterials for outpatient parenteral antimicrobial therapy : pharmacokinetic-pharmacodynamic considerations.

Authors:  Richard S Slavik; Peter J Jewesson
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 6.  Outpatient parenteral antimicrobial therapy and antibiotic stewardship: opponents or teammates?

Authors:  Ester Steffens; Charlotte Quintens; Inge Derdelinckx; Willy E Peetermans; Johan Van Eldere; Isabel Spriet; Annette Schuermans
Journal:  Infection       Date:  2018-11-15       Impact factor: 3.553

7.  Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin?

Authors:  Bruno Van Herendael; Axel Jeurissen; Paul M Tulkens; Erika Vlieghe; Walter Verbrugghe; Philippe G Jorens; Margareta Ieven
Journal:  Ann Intensive Care       Date:  2012-07-02       Impact factor: 6.925

8.  Stability and Compatibility Aspects of Drugs: The Case of Selected Cephalosporins.

Authors:  Szymon Tomczak; Aleksandra Gostyńska; Malwina Nadolna; Karolina Reisner; Marta Orlando; Anna Jelińska; Maciej Stawny
Journal:  Antibiotics (Basel)       Date:  2021-05-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.